Royston Ivor
SEC-identified person · CIK 1026765 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Viracta Therapeutics, Inc. VIRX | Director · CEO & President | filed 2021 - 2024 |
| Biocept INC BIOC | Director | filed 2014 - 2022 |
| Syndax Pharmaceuticals Inc SNDX | Director | filed 2016 - 2017 |
| Mmrglobal, Inc. MMRF.OB | Director | filed 2006 - 2016 |
| Avalon Pharmaceuticals INC AVRX | Director | filed 2006 - 2008 |
| VIA Pharmaceuticals, Inc. VIAP | Director | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.